Scholarlink

<p>Gut microbiota dysbiosis contributes to <i>Toxoplasma gondii</i> (<i>T. gondii</i>)-induced neuropsychiatric disorders (TNDs); however, the underlying mechanisms remain largely elusive. Here, we identified the critical role of butyrate-producing bacteria in TNDs in mice. Decreased abundance of butyrate-producing bacteria was consistently observed in patients with Alzheimer’s disease and <i>T. gondii</i>-infected mice. Dietary supplementation with <i>Clostridium butyricum</i> (<i>C. butyricum</i>), a gut commensal butyrate-producing bacterium, reversed gut microbiota dysbiosis, ameliorated intestinal barrier disruption and inflammation, and reduced endotoxemia. Coincidentally, <i>C. butyricum</i> administration suppressed microglial and astrocytic activation, rescued synaptic ultrastructure damage and synaptic loss, thus alleviating cognitive impairment and anxiety/depression-like behaviors. Mechanistically, <i>C. butyricum</i> treatment mitigated the abnormal synaptic pruning mediated by glial cells and C1q to prevent the neuropathology induced by <i>T. gondii</i> infection. Importantly, fecal microbiota transplantation from <i>C. butyricum</i>-supplemented mice into antibiotic-treated recipients recapitulated the therapeutic effects on gut and brain pathology observed in infected mice. Together, our findings suggest that <i>C. butyricum</i> ameliorates TNDs by modulating glial cell-mediated abnormal synaptic pruning <i>via</i> the gut-brain axis, highlighting the therapeutic potential efficacy of butyrate-producing bacteria against TNDs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clostridium butyricum ameliorates Toxoplasma gondii-induced neuropsychiatric disorders by attenuating glial-mediated synaptic pruning via the gut-brain axis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月10日

查看全文
  • Yiling Li,
  • Hongjin Wu,
  • Jiayi Yang,
  • Jensen G Weedor,
  • Haoxuan Ding,
  • Wenjing Cui,
  • Bingqian Cui,
  • Zhicheng He,
  • Wenjun Zhang,
  • Yihui Xing,
  • Fan Zeng,
  • Xufeng Huang,
  • Kuiyang Zheng,
  • Yujuan Shen,
  • Yinghua Yu,
  • Wei Pan,
  • Xiaoying Yang

摘要

Gut microbiota dysbiosis contributes to Toxoplasma gondii (T. gondii)-induced neuropsychiatric disorders (TNDs); however, the underlying mechanisms remain largely elusive. Here, we identified the critical role of butyrate-producing bacteria in TNDs in mice. Decreased abundance of butyrate-producing bacteria was consistently observed in patients with Alzheimer’s disease and T. gondii-infected mice. Dietary supplementation with Clostridium butyricum (C. butyricum), a gut commensal butyrate-producing bacterium, reversed gut microbiota dysbiosis, ameliorated intestinal barrier disruption and inflammation, and reduced endotoxemia. Coincidentally, C. butyricum administration suppressed microglial and astrocytic activation, rescued synaptic ultrastructure damage and synaptic loss, thus alleviating cognitive impairment and anxiety/depression-like behaviors. Mechanistically, C. butyricum treatment mitigated the abnormal synaptic pruning mediated by glial cells and C1q to prevent the neuropathology induced by T. gondii infection. Importantly, fecal microbiota transplantation from C. butyricum-supplemented mice into antibiotic-treated recipients recapitulated the therapeutic effects on gut and brain pathology observed in infected mice. Together, our findings suggest that C. butyricum ameliorates TNDs by modulating glial cell-mediated abnormal synaptic pruning via the gut-brain axis, highlighting the therapeutic potential efficacy of butyrate-producing bacteria against TNDs.